Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAVINA: Early HIV Diagnosis and Treatment in Newborns
NCT03642704Phase 4Completed
- Sponsor
- ANRS
- Start
- Feb 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zidovudine, lamivudine and nevirapine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Primary endpoint: Proportion of newborns who have received an HIV diagnosis and reinforced preventive antiretroviral treatment at birth at Day 2. Started Feb 2017; status: completed.
02
Drugs
zidovudinelamivudinenevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03642704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642704.